Press release
Urinary Tract Infections Pipeline Assessment (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals | Wockhardt, Iterum Therapeutics, VenatoRx, Helperby, Spexis, LUCA Biologics, Omnix Medical, Inmunotek S.L., Sinovent,
"Urinary Tract Infections Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Urinary Tract Infections Therapeutics Market.
The report provides a detailed description of the Urinary Tract Infections drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.
Get a Detailed Overview of the Urinary Tract Infections Clinical Trial Activities and Regulatory Developments in the domain:
https://www.delveinsight.com/report-store/urinary-tract-infections-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Urinary Tract Infections Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing Urinary Tract Infections therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Urinary Tract Infections treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging Urinary Tract Infections drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement in the Urinary Tract Infections treatment market.
Learn More about the Clinical and Commercial Development Activities in the Urinary Tract Infections Therapeutics Domain:
https://www.delveinsight.com/report-store/urinary-tract-infections-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
The Report Covers the Emerging Urinary Tract Infections Therapies Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
Route of Administration
Urinary Tract Infections pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Inhalation
• Inhalation/Intravenous/Oral
• Intranasal
• Intravenous
• Intravenous/ Subcutaneous
• Oral
• Oral/intranasal/subcutaneous
• Parenteral
• Subcutaneous
Molecule Type
Products have been categorized under various Molecule types such as
• Antibody
• Antisense oligonucleotides
• Immunotherapy
• Monoclonal antibody
• Peptides
• Protein
• Recombinant protein
• Small molecule
• Stem Cell
• Vaccine
Request for Sample PDF to Understand More About the Urinary Tract Infections Treatment Outlook and Future Perspectives:
https://www.delveinsight.com/sample-request/urinary-tract-infections-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Urinary Tract Infections Therapeutics Analysis
There are approx. 38+ key companies which are developing therapies for Urinary Tract Infections. Currently, Spero Therapeutics is leading the therapeutics market with its Urinary Tract Infections drug candidates in the most advanced stage of clinical development.
Urinary Tract Infections Companies in the Therapeutics Market Include:
Wockhardt, GlaxoSmithKline, Iterum Therapeutics, Spero Therapeutics, VenatoRx Pharmaceuticals, Helperby Therapeutics, Spexis, LUCA Biologics, Seed Health, Inc., Aelin Therapeutics, Omnix Medical, Inmunotek S.L., Sinovent Pty Ltd., Qilu Pharmaceuticals, Entasis Therapeutics, Adaptive Phage Therapeutics, Locus Biosciences, Nabriva Therapeutics, Utility Therapeutics, Zensun (Shanghai) Sci & Tech, Fedora Pharmaceuticals, Osel Inc., Evofem Biosciences, Enlivex, Fimbrion Therapeutics, Rebiotix, MerLion Pharmaceuticals, Allecra Therapeutics, Lakewood Amedex, Sumitomo Dainippon Pharma, Sihuan Pharmaceuticals, SuperTrans Medical, Asieris Pharmaceuticals, and others.
Emerging and Marketed Urinary Tract Infections Therapies Covered in the Report Include:
• Tebipenem HBr: Spero Therapeutics
• Sulopenem etzadroxil: Iterum Therapeutics
• Gepotidacin: GlaxoSmithKline
• Cefepime-taniborbactam: Venatorx Pharmaceuticals
And Many More
Get an in-depth Assessment of the Emerging Therapies and Urinary Tract Infections Companies Actively Working in the Market:
https://www.delveinsight.com/sample-request/urinary-tract-infections-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Table of Content
1. Report Introduction
2. Executive Summary
3. Urinary Tract Infections Current Treatment Patterns
4. Urinary Tract Infections - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Urinary Tract Infections Late-Stage Products (Phase-III)
7. Urinary Tract Infections Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Urinary Tract Infections Discontinued Products
13. Urinary Tract Infections Product Profiles
14. Urinary Tract Infections Companies
15. Urinary Tract Infections Drugs
16. Dormant and Discontinued Products
17. Urinary Tract Infections Unmet Needs
18. Urinary Tract Infections Future Perspectives
19. Urinary Tract Infections Analyst Review
20. Appendix
21. Report Methodology
Get Detailed Insights About the Reports Offerings:
https://www.delveinsight.com/sample-request/urinary-tract-infections-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Other Trending Healthcare Reports by DelveInsight -
• Osteoporosis Market
https://www.delveinsight.com/report-store/osteoporosis-market
• Carcinoid Tumor Syndrome Market
https://www.delveinsight.com/report-store/carcinoid-tumor-syndrome-market
• Migraine Market
https://www.delveinsight.com/report-store/migraine-market
• Emphysema Market
https://www.delveinsight.com/report-store/emphysema-market
• Substance use disorder Market
https://www.delveinsight.com/report-store/substance-use-disorder-market
• Tumor Ablation Market
https://www.delveinsight.com/report-store/tumor-ablation-market
• Campylobacter Infections Market
https://www.delveinsight.com/report-store/campylobacter-infections-market
• mRNA Vaccine and Therapeutics Market
https://www.delveinsight.com/report-store/mrna-vaccine-and-therapeutics-market
• Breast Pumps Market
https://www.delveinsight.com/report-store/breast-pumps-market
• Negative Pressure Wound Therapy Systems Market
https://www.delveinsight.com/report-store/negative-pressure-wound-therapy-systems-market
• Obsessive-Compulsive Disorder Market
https://www.delveinsight.com/report-store/obsessive-compulsive-disorder-market
• Diabetic Eye Disease Market
https://www.delveinsight.com/report-store/diabetic-eye-disease-market
• Seborrhoeic Dermatitis Market
https://www.delveinsight.com/report-store/seborrhoeic-dermatitis-market
• Hernia Repair Devices Market
https://www.delveinsight.com/report-store/hernia-repair-devices-market
Contact Info:
Shruti Thakur
Manager - Marketing & International Branding
Email: info@delveinsight.com
428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Urinary Tract Infections Pipeline Assessment (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals | Wockhardt, Iterum Therapeutics, VenatoRx, Helperby, Spexis, LUCA Biologics, Omnix Medical, Inmunotek S.L., Sinovent, here
News-ID: 3122300 • Views: …
More Releases from DelveInsight Business Research LLP
Myelofibrosis Pipeline Report 2025 by DelveInsight: Key Insights into Clinical S …
DelveInsight's "Myelofibrosis Pipeline Insight" report provides comprehensive insights about 35+ companies and 40+ pipeline drugs in the Myelofibrosis pipeline landscape. It covers the Myelofibrosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Myelofibrosis therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Stay ahead with the latest insights! Download DelveInsight's comprehensive Myelofibrosis…
Hemophilia Pipeline Landscape Report 2025: DelveInsight's Exclusive Report on Cu …
DelveInsight's "Hemophilia Pipeline Insight" report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in the Hemophilia pipeline landscape. It covers the Hemophilia pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hemophilia therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Stay ahead with the latest insights! Download DelveInsight's comprehensive Hemophilia…
DelveInsight's NMIBC Pipeline 2025: Unveiling Drug Development Progress, Clinica …
DelveInsight's, "Non Muscle Invasive Bladder Cancer Pipeline Insight" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Non Muscle Invasive Bladder Cancer pipeline landscape. It covers the Non Muscle Invasive Bladder Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Non Muscle Invasive Bladder Cancer therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive…
Hearing Loss Pipeline 2025 by DelveInsight: Exploring Novel Mechanisms of Action …
DelveInsight's "Hearing Loss Pipeline Insight" report provides comprehensive insights about 32+ companies and 35+ pipeline drugs in Hthe earing Loss pipeline landscape. It covers the Hearing Loss pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hearing Loss therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Stay ahead with the latest insights!…
More Releases for Infections
Campylobacter Infections Market Outlook Report 2032 | Campylobacter Infections M …
DelveInsight's "Campylobacter Infections Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Campylobacter Infections, historical and forecasted epidemiology as well as the Campylobacter Infections market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Campylobacter Infections market report provides current treatment practices, emerging drugs, Campylobacter Infections market share of the individual therapies, and current and forecasted Campylobacter Infections market size…
Point of Care Molecular Diagnostics Market Size Worth $5,665.3 Million By 2028: …
Global “Point of Care Molecular Diagnostics Market” 2021 –2028 Research Report is an extensive Industry report contains an introduction on new trends that can guide the businesses performing in the Life Science industry to recognize the market and make the strategies for their industry growth accordingly. The Point of Care Molecular Diagnostics research report study the market scope, Industry segment, key drivers for development, major segments, and SWOT Analysis.
Global PoC…
Amoxicillin Drugs Market Expansion Projected to Gain an Uptick During 2018 to 20 …
Amoxicillin Drugs: Market Insights
Amoxicillin drugs is a form of generic drugs of Amoxil branded drug commonly used in the treatment of bacterial infections. The Amoxicillin drugs fall under the drug class of β-lactam antibiotic. The increasing number of bacterial infections around the world, especially, in the developing and low-income countries is one of the reasons for the growing demand for Amoxicillin drugs and hence, boosting the growth of Amoxicillin drugs…
Burkholderia Infections Market
Burkholderia infections are caused by Burkholderia cepacia. It is a gram negative bacillus found in aquatic environment. It is a low virulent bacteria and is a frequent colonizer of fluids used in the hospitals such as IV fluid, irrigation solution etc. B. cepacia can cause health problems to some people such as patients suffering from weakened immune system or chronic lung diseases. Burkholderia infection symptom can vary widely in people,…
Burkholderia Infections Market
Burkholderia infections are caused by Burkholderia cepacia. It is a gram negative bacillus found in aquatic environment. It is a low virulent bacteria and is a frequent colonizer of fluids used in the hospitals such as IV fluid, irrigation solution etc. B. cepacia can cause health problems to some people such as patients suffering from weakened immune system or chronic lung diseases. Burkholderia infection symptom can vary widely in people,…
Acinetobacter Infections Treatment Market is Propelled by Increasing Incidence R …
Global Acinetobacter Infections Treatment Market: Overview
Acinetobacter baumannii is a rod shaped gram-negative coccobacillus bacterium. This bacterium is becoming an important cause of hospital derived bacterial infection affecting people with weakened immune system. Acinetobacter infections usually affect organ systems, which have a high content of fluid (e.g. peritoneal fluid, respiratory tract, urinary tract, cerebrospinal fluid etc.) leading to infections related to continuous ambulatory peritoneal dialysis and nocosomial pneumonia. At present, acinetobacter…
